Haber DA - Search Results

1

Inhibition of mutant EGFR in lung cancer cells triggers SOX2-FOXO6-dependent survival pathways.

Rothenberg SM, Concannon K, Cullen S, Boulay G, Turke AB, Faber AC, Lockerman EL, Rivera MN, Engelman JA, Maheswaran S, Haber DA. Rothenberg SM, et al. Among authors: haber da. Elife. 2015 Feb 16;4:e06132. doi: 10.7554/eLife.06132. Elife. 2015. PMID: 25686219 Free PMC article.

2

Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways.

Sordella R, Bell DW, Haber DA, Settleman J. Sordella R, et al. Among authors: haber da. Science. 2004 Aug 20;305(5687):1163-7. doi: 10.1126/science.1101637. Epub 2004 Jul 29. Science. 2004. PMID: 15284455

3

Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib.

Kwak EL, Sordella R, Bell DW, Godin-Heymann N, Okimoto RA, Brannigan BW, Harris PL, Driscoll DR, Fidias P, Lynch TJ, Rabindran SK, McGinnis JP, Wissner A, Sharma SV, Isselbacher KJ, Settleman J, Haber DA. Kwak EL, et al. Among authors: haber da. Proc Natl Acad Sci U S A. 2005 May 24;102(21):7665-70. doi: 10.1073/pnas.0502860102. Epub 2005 May 16. Proc Natl Acad Sci U S A. 2005. PMID: 15897464 Free PMC article.

4

Overcoming acquired resistance to Iressa/Tarceva with inhibitors of a different class.

Haber DA, Settleman J. Haber DA, et al. Cell Cycle. 2005 Aug;4(8):1057-9. Epub 2005 Aug 26. Cell Cycle. 2005. PMID: 15970680

5

Wilms' tumour: connecting tumorigenesis and organ development in the kidney.

Rivera MN, Haber DA. Rivera MN, et al. Among authors: haber da. Nat Rev Cancer. 2005 Sep;5(9):699-712. doi: 10.1038/nrc1696. Nat Rev Cancer. 2005. PMID: 16110318 Review.

6

Inherited susceptibility to lung cancer may be associated with the T790M drug resistance mutation in EGFR.

Bell DW, Gore I, Okimoto RA, Godin-Heymann N, Sordella R, Mulloy R, Sharma SV, Brannigan BW, Mohapatra G, Settleman J, Haber DA. Bell DW, et al. Among authors: haber da. Nat Genet. 2005 Dec;37(12):1315-6. doi: 10.1038/ng1671. Epub 2005 Oct 30. Nat Genet. 2005. PMID: 16258541

7

Frequent met oncogene amplification in a Brca1/Trp53 mouse model of mammary tumorigenesis.

Smolen GA, Muir B, Mohapatra G, Barmettler A, Kim WJ, Rivera MN, Haserlat SM, Okimoto RA, Kwak E, Dahiya S, Garber JE, Bell DW, Sgroi DC, Chin L, Deng CX, Haber DA. Smolen GA, et al. Among authors: haber da. Cancer Res. 2006 Apr 1;66(7):3452-5. doi: 10.1158/0008-5472.CAN-05-4181. Cancer Res. 2006. PMID: 16585167

8

Summary statement: novel agents in the treatment of lung cancer: advances in epidermal growth factor receptor-targeted agents.

Lynch TJ, Adjei AA, Bunn PA Jr, Eisen TG, Engelman J, Goss GD, Haber DA, Heymach JV, Jänne PA, Johnson BE, Johnson DH, Lilenbaum RC, Meyerson M, Sandler AB, Sequist LV, Settleman J, Wong KK, Hart CS. Lynch TJ, et al. Among authors: haber da. Clin Cancer Res. 2006 Jul 15;12(14 Pt 2):4365s-4371s. doi: 10.1158/1078-0432.CCR-06-1005. Clin Cancer Res. 2006. PMID: 16857812 No abstract available.

9

An X chromosome gene, WTX, is commonly inactivated in Wilms tumor.

Rivera MN, Kim WJ, Wells J, Driscoll DR, Brannigan BW, Han M, Kim JC, Feinberg AP, Gerald WL, Vargas SO, Chin L, Iafrate AJ, Bell DW, Haber DA. Rivera MN, et al. Among authors: haber da. Science. 2007 Feb 2;315(5812):642-5. doi: 10.1126/science.1137509. Epub 2007 Jan 4. Science. 2007. PMID: 17204608

10

Response to treatment and survival of patients with non-small cell lung cancer undergoing somatic EGFR mutation testing.

Sequist LV, Joshi VA, Jänne PA, Muzikansky A, Fidias P, Meyerson M, Haber DA, Kucherlapati R, Johnson BE, Lynch TJ. Sequist LV, et al. Among authors: haber da. Oncologist. 2007 Jan;12(1):90-8. doi: 10.1634/theoncologist.12-1-90. Oncologist. 2007. PMID: 17285735 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

312 results

Search Page